This is the first time that the mechanism for PGC1β-mediated HKDC1 expression has been discovered in breast cancers, and this provides a new strategy for cancer therapy through targeting the PGC1β/HKDC1 signaling pathway. The gene discussed is PPARGC1B; the disease is breast cancer.